Mark Bach is the founder of ShouTi. ShouTi has raised $158M in total funding. Latest round: Series B. Based in South San Francisco, CA.
Mark Bach is the Chief Medical Officer at ShouTi, a clinical-stage biopharmaceutical company that develops life-changing medicines using advanced computational and structure-based technology. The company has raised $158 million in funding to advance its discovery platform and clinical-stage pipeline.
Full founder directory · Investor directory · Company funding database · Fundraising library